Literature DB >> 12822754

Dilatation of the pulmonary veins in atrial fibrillation: a transesophageal echocardiographic evaluation.

Christian Knackstedt1, Laurent Visser, Jurgita Plisiene, Markus Zarse, Matthias Waldmann, Karl Mischke, Karl-Christian Koch, Rainer Hoffmann, Andreas Franke, Peter Hanrath, Patrick Schauerte.   

Abstract

Ectopic beats originating from sleeves of atrial tissue within the pulmonary veins (PVs) can induce and sustain paroxysmal atrial fibrillation (AF). Left atrial stretch and dilatation favors the development of atrial ectopy and AF. Similarly, PV dilatation, if present, might trigger PV ectopy in patients with AF. This study was designed to evaluate whether PV dilatation is present in patients with nonfocal AF and whether the PV diameter correlates to the left atrial diameter (LAD). The diameters of the right superior (RSPV) and left superior PV (LSPV) were measured at the ostium and at a depth of 1 cm in 170 patients (AF, n = 75; sinus rhythm [SR], n = 95) using transesophageal echocardiography. The LAD was determined by transthoracic echocardiography. The diameters of the PVs were significantly larger in patients with AF than in patients with SR (LSPV(ostium): AF 13.6 +/- 3.5 mm vs SR 10.6 +/- 2.7 mm, P < 0.001; LSVP(1cm): AF 12.5 +/- 2.9 mm vs SR 10.2 +/- 2.5 mm, P < 0.001; RSPV(ostium): AF 13.9 +/- 3.5 mm vs SR 11.7 +/- 2.9 mm, P < 0.001; RSVP(1cm): AF 12.8 +/- 2.8 mm vs SR 10.6 +/- 2.6 mm, P < 0.05). Similarly, LAD was larger in patients with AF (44.7 +/- 7.7 mm) as compared to patients with SR (38.8 +/- 6.8 mm, P < 0.001). Neither for the SR nor the AF group did the PV size correlate to the LAD. AF is associated with a significant enlargement of the RSPV, LSPV, and LAD. There is no correlation between LAD and PV diameters. This raises the question whether PV dilatation in patients with AF is a cause or a consequence of AF and whether it may contribute to the development and perpetuation of AF.

Entities:  

Mesh:

Year:  2003        PMID: 12822754     DOI: 10.1046/j.1460-9592.2003.t01-1-00196.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

Review 1.  The Role of Echocardiography as a Predictor of the Incidence and Progression of Atrial Fibrillation.

Authors:  Rui Providência; Sérgio Barra; Luís Paiva
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 2.  Role of Echocardiography in Atrial Fibrillation Ablation.

Authors:  C Y Andrew; Allan L Klein
Journal:  J Atr Fibrillation       Date:  2011-12-20

3.  Percutaneous pulmonary vein cryoablation to treat atrial fibrillation.

Authors:  Tom Wong; Vias Markides; Nicholas S Peters; D Wyn Davies
Journal:  J Interv Card Electrophysiol       Date:  2004-10       Impact factor: 1.900

4.  Centerline tracking for quantification of reverse structural remodeling of the pulmonary veins following cardiac ablation therapy.

Authors:  Maryam E Rettmann; Mia S Gunawan; David R Holmes; Jerome F Breen; Douglas L Packer; Richard A Robb
Journal:  Acad Radiol       Date:  2012-08-11       Impact factor: 3.173

5.  Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Martin R Prince; Eric A Hoffman; David A Bluemke; Chia-Ying Liu; Dan Rabinowitz; Katja Hueper; Megha A Parikh; Antoinette S Gomes; Erin D Michos; João A C Lima; R Graham Barr
Journal:  Chest       Date:  2013-10       Impact factor: 9.410

6.  Assessments of pulmonary vein and left atrial anatomical variants in atrial fibrillation patients for catheter ablation with cardiac CT.

Authors:  Jing Chen; Zhi-Gang Yang; Hua-Yan Xu; Ke Shi; Qi-Hua Long; Ying-Kun Guo
Journal:  Eur Radiol       Date:  2016-05-26       Impact factor: 5.315

7.  Echocardiographic Parameters Associated With Asymmetrical Structural Remodeling In Patients With Or Without Atrial Fibrillation.

Authors:  Mariana Floria; Jacques Jamart; Erwin Schroeder; Catalina Arsenescu Georgesu
Journal:  J Atr Fibrillation       Date:  2014-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.